Ipca Laboratories is currently trading at Rs. 666.85, up by 2.30 points or 0.35% from its previous closing of Rs. 664.55 on the BSE.
The scrip opened at Rs. 668.50 and has touched a high and low of Rs. 668.50 and Rs. 664.05 respectively. So far 3552 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 899.30 on 30-Jun-2014 and a 52 week low of Rs. 591.25 on 09-Feb-2015.
Last one week high and low of the scrip stood at Rs. 685.60 and Rs. 657.00 respectively. The current market cap of the company is Rs. 8388.45 crore.
The promoters holding in the company stood at 45.89% while Institutions and Non-Institutions held 33.04% and 21.07% respectively.
IPCA Laboratories has sold 0.81% stake in Mangalam Drugs & Organics for Rs 36.3 lakh. It has sold over 1 lakh shares at a price of Rs 33.68 on the NSE.
Mangalam Drugs & Organics is engaged in manufacturing of Active Pharmaceutical Ingredients APIs, Intermediates at VAPI, Gujarat.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |